πŸ‡ΊπŸ‡Έ FDA
Patent

US 12209120

Activatable anti-VEGF scFv

granted A61PA61P35/00A61P43/00

Quick answer

US patent 12209120 (Activatable anti-VEGF scFv) held by The Regents of the University of California expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P35/00, A61P43/00, A61P9/00